Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab (Neurology and Therapy, (2022), 11, 2, (741-758), 10.1007/s40120-022-00341-z)

Anne H. Cross; Silvia Delgado; Mario Habek; Maria Davydovskaya; Brian J. Ward; Bruce A.C. Cree; Natalia Totolyan; Ratnakar Pingili; Linda Mancione; Xixi Hu; Roseanne Sullivan; Wendy Su; Ronald Zielman; Ayan Das Gupta; Xavier Montalban; Kevin Winthrop

doi:10.1007/s40120-022-00346-8

Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab (Neurology and Therapy, (2022), 11, 2, (741-758), 10.1007/s40120-022-00341-z)

Anne H. Cross
, Silvia Delgado
, Mario Habek
, Maria Davydovskaya
, Brian J. Ward
, Bruce A.C. Cree
, Natalia Totolyan
, Ratnakar Pingili
, Linda Mancione
, Xixi Hu
, Roseanne Sullivan
, Wendy Su
, Ronald Zielman
, Ayan Das Gupta
, Xavier Montalban
, Kevin Winthrop

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

In the published article a few errors have been identified, these have subsequently been rectified. Alterations were also made to sentences and reference numbering to improve the clarity of sentences and better reflect the published literature. These changes did not impact upon the conclusions of the article.

Original language	English
Pages (from-to)	759-762
Number of pages	4
Journal	Neurology and Therapy
Volume	11
Issue number	2
DOIs	https://doi.org/10.1007/s40120-022-00346-8
State	Published - Jun 2022

Access to Document

10.1007/s40120-022-00346-8

Cite this

Cross, A. H., Delgado, S., Habek, M., Davydovskaya, M., Ward, B. J., Cree, B. A. C., Totolyan, N., Pingili, R., Mancione, L., Hu, X., Sullivan, R., Su, W., Zielman, R., Gupta, A. D., Montalban, X., & Winthrop, K. (2022). Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab (Neurology and Therapy, (2022), 11, 2, (741-758), 10.1007/s40120-022-00341-z). Neurology and Therapy, 11(2), 759-762. https://doi.org/10.1007/s40120-022-00346-8

@article{5a4a8e0f1f0749eab99ff0fd3fdcf40e,

title = "Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab (Neurology and Therapy, (2022), 11, 2, (741-758), 10.1007/s40120-022-00341-z)",

abstract = "In the published article a few errors have been identified, these have subsequently been rectified. Alterations were also made to sentences and reference numbering to improve the clarity of sentences and better reflect the published literature. These changes did not impact upon the conclusions of the article.",

author = "Cross, \{Anne H.\} and Silvia Delgado and Mario Habek and Maria Davydovskaya and Ward, \{Brian J.\} and Cree, \{Bruce A.C.\} and Natalia Totolyan and Ratnakar Pingili and Linda Mancione and Xixi Hu and Roseanne Sullivan and Wendy Su and Ronald Zielman and Gupta, \{Ayan Das\} and Xavier Montalban and Kevin Winthrop",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

month = jun,

doi = "10.1007/s40120-022-00346-8",

language = "English",

volume = "11",

pages = "759--762",

journal = "Neurology and Therapy",

issn = "2193-8253",

number = "2",

}

Cross, AH, Delgado, S, Habek, M, Davydovskaya, M, Ward, BJ, Cree, BAC, Totolyan, N, Pingili, R, Mancione, L, Hu, X, Sullivan, R, Su, W, Zielman, R, Gupta, AD, Montalban, X & Winthrop, K 2022, 'Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab (Neurology and Therapy, (2022), 11, 2, (741-758), 10.1007/s40120-022-00341-z)', Neurology and Therapy, vol. 11, no. 2, pp. 759-762. https://doi.org/10.1007/s40120-022-00346-8

Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab (Neurology and Therapy, (2022), 11, 2, (741-758), 10.1007/s40120-022-00341-z). / Cross, Anne H.; Delgado, Silvia; Habek, Mario et al.
In: Neurology and Therapy, Vol. 11, No. 2, 06.2022, p. 759-762.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab (Neurology and Therapy, (2022), 11, 2, (741-758), 10.1007/s40120-022-00341-z)

AU - Cross, Anne H.

AU - Delgado, Silvia

AU - Habek, Mario

AU - Davydovskaya, Maria

AU - Ward, Brian J.

AU - Cree, Bruce A.C.

AU - Totolyan, Natalia

AU - Pingili, Ratnakar

AU - Mancione, Linda

AU - Hu, Xixi

AU - Sullivan, Roseanne

AU - Su, Wendy

AU - Zielman, Ronald

AU - Gupta, Ayan Das

AU - Montalban, Xavier

AU - Winthrop, Kevin

PY - 2022/6

Y1 - 2022/6

N2 - In the published article a few errors have been identified, these have subsequently been rectified. Alterations were also made to sentences and reference numbering to improve the clarity of sentences and better reflect the published literature. These changes did not impact upon the conclusions of the article.

AB - In the published article a few errors have been identified, these have subsequently been rectified. Alterations were also made to sentences and reference numbering to improve the clarity of sentences and better reflect the published literature. These changes did not impact upon the conclusions of the article.

UR - https://www.scopus.com/pages/publications/85129307271

U2 - 10.1007/s40120-022-00346-8

DO - 10.1007/s40120-022-00346-8

M3 - Comment/debate

C2 - 35503396

AN - SCOPUS:85129307271

SN - 2193-8253

VL - 11

SP - 759

EP - 762

JO - Neurology and Therapy

JF - Neurology and Therapy

IS - 2

ER -

Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab (Neurology and Therapy, (2022), 11, 2, (741-758), 10.1007/s40120-022-00341-z)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this